Literature DB >> 21418374

Terminal arteriolar network structure/function and plasma cytokine levels in db/db and ob/ob mouse skeletal muscle.

Melissa K Georgi1, Jacqueline Vigilance, Anthony M Dewar, Mary D Frame.   

Abstract

OBJECTIVE: To investigate the terminal arteriolar network structure and function in relation to circulating plasma cytokine levels in db/db, ob/ob, and their genetic background control, C57/bl6, mice.
METHODS: Arteriolar network size and erythrocyte distribution were observed in the resting cremaster muscle (n = 45, pentobarbital 50 mg/kg i.p.). Structural remodeling and inflammatory state were related to 21 plasma cytokine levels.
RESULTS: db/db networks were shorter, had fewer branches, and smaller diameters than C57/bl6 controls. ob/ob networks were longer, with similar branch numbers, however with non-uniform diameters. Shunting of erythrocytes to the specific terminal arteriolar branches of the network (functional rarefaction) was prominent in db/db and ob/ob, with further evidence of shunting between networks seen as no flow to 50% of ob/ob arteriolar networks.
CONCLUSIONS: Altered levels of plasma cytokines are consistent with structural remodeling seen in db/db, and a pro-inflammatory state for both db/db and ob/ob. Differences in network structure alone predict overall reduced uniform oxygen delivery in db/db or ob/ob. Shunting probably increases heterogeneous oxygen delivery and is strain-dependent.
© 2011 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21418374      PMCID: PMC3081372          DOI: 10.1111/j.1549-8719.2011.00084.x

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  78 in total

1.  Occlusion of cremaster collateral circulation alters microvascular reactivity.

Authors:  K Nishigaki; J E Faber; M Ohyanagi
Journal:  Microvasc Res       Date:  1991-03       Impact factor: 3.514

2.  Angiogenesis and inflammation face off.

Authors:  Beat A Imhof; Michel Aurrand-Lions
Journal:  Nat Med       Date:  2006-02       Impact factor: 53.440

3.  Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction.

Authors:  P Soltesz; H Der; K Veres; R Laczik; S Sipka; G Szegedi; P Szodoray
Journal:  Rheumatology (Oxford)       Date:  2008-09-09       Impact factor: 7.580

4.  Arteriolar control of capillary cell flow in striated muscle.

Authors:  T E Sweeney; I H Sarelius
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

5.  Interleukin-2 protects against endothelial dysfunction induced by high glucose levels in rats.

Authors:  Ling-Bo Qian; Hui-Ping Wang; Wei-Ling Qiu; He Huang; Iain C Bruce; Qiang Xia
Journal:  Vascul Pharmacol       Date:  2006-06-12       Impact factor: 5.773

6.  Direct measurement of microvessel hematocrit, red cell flux, velocity, and transit time.

Authors:  I H Sarelius; B R Duling
Journal:  Am J Physiol       Date:  1982-12

7.  Cuttine edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice.

Authors:  Pedro B Simpson; Monica S Mistry; Richard A Maki; Weidong Yang; David A Schwarz; Eric B Johnson; Francisco M Lio; David G Alleva
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

8.  Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

Authors:  Susanna M Hofmann; Heng-Jiang Dong; Zhu Li; Weijing Cai; Jennifer Altomonte; Swan N Thung; Feng Zeng; Edward A Fisher; Helen Vlassara
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

9.  Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice.

Authors:  Maria Pini; Giamila Fantuzzi
Journal:  J Leukoc Biol       Date:  2009-09-10       Impact factor: 4.962

10.  Adult microvascular disturbances as a result of juvenile onset diabetes in Db/Db mice.

Authors:  H G Bohlen; B A Niggl
Journal:  Blood Vessels       Date:  1979
View more
  7 in total

1.  Vasoactive effects of stable aqueous suspensions of single walled carbon nanotubes in hamsters and mice.

Authors:  Mary D Frame; Anthony M Dewar; Sayan Mullick Chowdhury; Balaji Sitharaman
Journal:  Nanotoxicology       Date:  2013-09-30       Impact factor: 5.913

Review 2.  Microvascular repair: post-angiogenesis vascular dynamics.

Authors:  Amanda J LeBlanc; Laxminarayanan Krishnan; Christopher J Sullivan; Stuart K Williams; James B Hoying
Journal:  Microcirculation       Date:  2012-11       Impact factor: 2.628

3.  Oral nitrite therapy improves vascular function in diabetic mice.

Authors:  Amy L Sindler; Kimberly Cox-York; Lauren Reese; Nathan S Bryan; Douglas R Seals; Christopher L Gentile
Journal:  Diab Vasc Dis Res       Date:  2015-02-12       Impact factor: 3.291

4.  Obesity promotes PhIP-induced small intestinal carcinogenesis in hCYP1A-db/db mice: involvement of mutations and DNA hypermethylation of Apc.

Authors:  Hong Wang; Anna Liu; Yingyi Kuo; Eric Chi; Xu Yang; Lanjing Zhang; Chung S Yang
Journal:  Carcinogenesis       Date:  2016-05-02       Impact factor: 4.944

5.  Impaired Coronary and Renal Vascular Function in Spontaneously Type 2 Diabetic Leptin-Deficient Mice.

Authors:  Helena U Westergren; Julia Grönros; Suvi E Heinonen; Tasso Miliotis; Karin Jennbacken; Alan Sabirsh; Anette Ericsson; Ann-Cathrine Jönsson-Rylander; Sara Svedlund; Li-Ming Gan
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

6.  Anti-inflammatory effects of Lefty-1 in renal tubulointerstitial inflammation via regulation of the NF-κB pathway.

Authors:  Lijun Zhang; Changgeng Xu; Wei Hu; Pin Wu; Cong Qin; Jie Zhang
Journal:  Int J Mol Med       Date:  2017-12-18       Impact factor: 4.101

7.  Investigation of microvascular morphological measures for skeletal muscle tissue oxygenation by image-based modelling in three dimensions.

Authors:  B Zeller-Plumhoff; K R Daly; G F Clough; P Schneider; T Roose
Journal:  J R Soc Interface       Date:  2017-10       Impact factor: 4.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.